Cases & Deals

ArunA Biomedical issues $3.7 million of Common Stock in Reg D offering

Clients ArunA Biomedical, Inc.

Jones Day advised ArunA Biomedical, Inc., a manufacturer of technologies in human stem cell research for use in drug discovery and development, in connection with its issuance of $3.7 million of Common Stock in a Regulation D offering.